Gufic Biosciences - Quaterly Results

20 May 2022 Evaluate
The March 2022 quarter revenue stood at Rs. 1621.93 millions, up 22.94% as compared to Rs. 1319.29 millions during the corresponding quarter last year.Net profit for the quarter ended March 2022 increased significantly by 57.45% to Rs. 202.65 millions from Rs. 128.71 millions.Operating Profit saw a handsome growth to 315.61 millions from 244.03 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1621.93 1319.29 22.94 7791.56 4876.99 59.76 7791.56 4876.99 59.76
Other Income 0.41 6.56 -93.75 31.04 37.33 -16.85 31.04 37.33 -16.85
PBIDT 315.61 244.03 29.33 1488.20 876.53 69.78 1488.20 876.53 69.78
Interest 10.57 28.72 -63.20 48.47 136.33 -64.45 48.47 136.33 -64.45
PBDT 305.04 215.31 41.67 1439.73 740.20 94.51 1439.73 740.20 94.51
Depreciation 43.27 44.82 -3.46 171.34 163.08 5.06 171.34 163.08 5.06
PBT 261.77 170.49 53.54 1268.39 577.12 119.78 1268.39 577.12 119.78
TAX 59.12 41.78 41.50 309.98 134.80 129.96 309.98 134.80 129.96
Deferred Tax -7.38 18.73 -139.40 -11.52 20.11 -157.28 -11.52 20.11 -157.28
PAT 202.65 128.71 57.45 958.41 442.32 116.68 958.41 442.32 116.68
Equity 96.94 96.94 0.00 96.94 96.94 0.00 96.94 96.94 0.00
PBIDTM(%) 19.46 18.50 5.20 19.10 17.97 6.27 19.10 17.97 6.27

Gufic Biosciences Share Price

321.80 -4.40 (-1.35%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.